Japan· JP-2219403G1020
フルマゼニル
A flumazenil product containing フルマゼニル, registered in Japan by テルモ, on the national reimbursement list. The same ATC class is registered in 17 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Flumazenil is registered in 17 of 19 countries.
Countries holding a registration under ATC V03AB25 (flumazenil), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 9 of them publish a price we can compare per daily dose
Flumazenil · ATC V03AB25
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- フルマゼニル
- Manufacturer
- テルモ
- Country
- Japan (JP)
- ATC code
- V03AB25
- ATC class
- Flumazenil
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for flumazenil.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flumazenil · interactions on record
63 records
- 11 severe
- 16 moderate
- 3 minor
- 33 info
Most severe, free to view
- DoxepinD04AX01severe
- DesipramineN06AA01severe
- ImipramineN06AA02severe
- ClomipramineN06AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under V03AB25
Flumazenil, as other registers publish it.
- GermanyAnexateCheplapharm Arzneimittel Gmbh
- BelgiumAnexate 0.5 mg/5 mlCheplapharm Arzneimittel
- IrelandAnexate 500 micrograms/5ml, solution for injection or infusionCheplapharm Arzneimittel GmbH
- United KingdomAnexate 500micrograms/5ml solution for injection ampoulesRoche Products Ltd
- NetherlandsAnexate, 0,5 mg/5 ml en 1,0 mg/ 10 ml oplossing voor injectieCHEPLAPHARM Arzneimittel GmbH
- SwitzerlandAnexate, InjektionslösungCheplapharm Schweiz GmbH
- SwitzerlandAnexate, InjektionslösungCheplapharm Schweiz GmbH
- United StatesFlumazenilHikma Pharmaceuticals USA Inc.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be8a9727-c224-44b7-bee0-6ea82410f14c GET /v1/drugs/be8a9727-c224-44b7-bee0-6ea82410f14c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "０．５ｍｇ５ｍＬ１筒",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2219403G1020",
"category": "注射薬",
"price_yen": 1135,
"generic_name": "フルマゼニル",
"product_name_jp": null,
"therapeutic_class": "2219",
"transitional_expiry": null
}See everything about flumazenil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.